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Abstract
Summary Periostin (POSTN) as a regulator of osteoblast
differentiation and bone formation may affect susceptibility
to osteoporosis. This study suggests POSTN as a candidate
gene for bone mineral density (BMD) variation and verte-
bral fracture risk, which could better our understanding
about the genetic pathogenesis of osteoporosis and will be
useful in clinic in the future.
Introduction The genetic determination of osteoporosis is
complex and ill-defined. Periostin (POSTN), an extracellu-
lar matrix secreted by osteoblasts and a regulator of osteo-
blast differentiation and bone formation, may affect
susceptibility to osteoporosis.
Methods We adopted a tag-single nucleotide polymorphism
(SNP) based association method followed by imputation-
based verification and identification of a causal variant. The
association was investigated in 1,572 subjects with extreme-
BMD and replicated in an independent population of 2,509
subjects. BMD was measured by dual X-ray absorptiometry.
Vertebral fractures were identified by assessing vertebral height
from X-rays of the thoracolumbar spine. Association analyses
were performed with PLINK toolset and imputation analyses
with MACH software. The top imputation finding was subse-
quently validated by genotyping. Interactions between POSTN
and another BMD-related candidate gene sclerostin (SOST)
were analyzed using MDR program and validated by logistical
regression analyses. The putative transcription factor binding
with target sequence was confirmed by electrophoretic mobility
shift assay (EMSA).
Results Several SNPs of POSTN were associated with BMD
or vertebral fractures. The most significant polymorphism was
rs9547970, located at the −2,327 bp upstream (P06.8×10−4) of
POSTN. Carriers of the minor allele G per copy of rs9547970
had 1.33 higher risk of vertebral fracture (P00.007). An inter-
active effect between POSTN and SOST upon BMD variation
was suggested (P<0.01). A specific binding of CDX1 to the
sequence of POSTN with the major allele A of rs9547970 but
not the variant G allele was confirmed by EMSA.
Conclusions Our results suggest POSTN as a candidate
gene for BMD variation and vertebral fracture risk.
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Introduction
Osteoporosis is a common skeletal disorder characterized by
compromised bone strength leading to an increased risk of
fracture. Bone mineral density (BMD) is a widely used
proxy measure and accounts for ∼70% of bone strength
[1]. Genetic studies have firmly established that BMD is
under strong genetic control with a heritability estimate of
0.6–0.85 [2–4]. In the last few decades, many linkage and
association studies have been conducted to identify genes
that underlie low bone mass and reported some disease-
related genes. Nevertheless, despite several genome-wide
association studies (GWAS) that have attempted to unravel
the genetic components of osteoporosis, the loci identified
thus far combined account for <5% of the variance in BMD
[5]. Some truly associated variants might be filtered out in
current GWAS, due to the highly stringent method used for
the correction of multiple testing, which could inflate the
false-negative rate. While GWAS enables high-throughout
evaluation of thousands of single nucleotide polymorphisms
(SNPs), many of these markers have no known function. In
an attempt to further understand the genetic pathogenesis
that is responsible for the predisposition to or progression of
osteoporosis, the association study based on candidate genes
with prior functional knowledge of their influence on bone
metabolism remains an attractive and cost-effective way to
identify genes and variants for osteoporosis.
Bone is a highly dynamic structure that undergoes con-
stant remodeling. Osteoporosis occurs when bone resorption
by osteoclasts exceeds bone formation by osteoblasts. Peri-
ostin (POSTN) is an extracellular matrix secreted by osteo-
blasts. It regulates the recruitment and adhesion of
osteoprogenitors from essential sources such as bone mar-
row and blood [6]. POSTN is a member of the vitamin-K-
dependent gamma carboxylated protein family and is ho-
mologous to other family members such as fasciclin I,
MPB70, and bIG-H3 proteins. All these secreted proteins
regulate cell adhesion [7, 8]. The extracellular domain of
POSTN is evolutionarily conserved from humans to bacteria
[9]. POSTN was first identified in MC3T3-E1 osteoblast-
like cells [8], and it was preferentially expressed in perios-
teum in vivo [10]. The overexpression of a basic helix–
loop–helix transcription factor, Twist, is related to the in-
creased expression of POSTN by binding to its promoter in
preosteoblasts [11]. Twist plays a key regulatory role in
early osteogenesis [12]. Inactivation of POSTN leads to a
severe reduction of osteoblast-specific differentiation
markers, such as type I collagen, osteocalcin, osteopontin,
and alkaline phosphatase [13]. Recently, an animal study
demonstrated that the Postn protein is essential for the
down-regulation of sclerostin (Sost) and thereby plays an
important role in the determination of bone mass and micro-
structural in response to loading [14]. SOST is important in
bone and mineral metabolism, and its polymorphisms have
previously been shown to associate with BMD [15].
These functional reports propose a role for POSTN in
human osteoblast differentiation and bone formation. This
prompted us to perform a genetic association study between
SNPs along the POSTN gene and osteoporosis phenotypes.
We first selected the tag SNPs (tSNPs) of the POSTN gene
and studied their relationship with BMD variation in a Hong
Kong Southern Chinese (HKSC) population that included
1,572 subjects with extreme BMD. We then used the impu-
tation approach to study the phenotypic associations with a
more extensive fine map of polymorphisms around the gene
region using the Asian population data of HapMap phase II
as the reference. The significant association was further
confirmed in another independent Hong Kong Osteoporosis
Study (HKOS) prospective cohort with BMD (n02,509)
and vertebral fracture (n01,746) data. In addition, the find-
ing from animal study may suggest the interactive effect
between POSTN and SOST genes on regulating of BMD;
thus, the interaction analysis was also conducted between
these two genes in this study. Finally, the potentially bio-
logical function of the identified variant of POSTN gene was
studied.
Methods
Subjects
HKSC cohort with extreme BMD A total of 1,572 unrelated
subjects (81.3% women) with either high or low BMD were
selected from a growing database at the Osteoporosis Centre
of the University of Hong Kong (>9,000 HKSC volunteers).
Subjects that were reported to have diseases or environmen-
tal factors that may affect BMD and bone metabolism were
excluded. The recruitment procedure and exclusion criteria
have been detailed elsewhere [16]. BMD was measured at
the lumbar spine (LS) and femoral neck (FN) by dual X-ray
absorptiometry (Hologic QDR4500, Waltham, MA, USA).
The in vivo precision of the machine was 1.2% and 1.5% for
LS and FN BMD, respectively. Low BMD subjects were
individuals with a BMD z-score≤−1.28 (the lowest 10% of
the population) at either LS or FN; high BMD subjects had
BMD z-score≥+1.0 (the highest 15% of the population) at
one or both skeletal sites [17, 18]. Height was measured
using a wall-mount stadiometer and weight with an elec-
tronic scale.
HKOS prospective cohort (for replication) This random
population is also a part of the on-going HKSC database
with BMD (n02,509) and vertebral fracture (n01,746) data.
A total of 1,794 unrelated postmenopausal women
(≥45 years) and 715 men (≥50 years), without receiving
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osteoporosis treatment or any drug known to influence bone
metabolism, were included as described previously [19].
Vertebral fractures were assessed by digital measurements
of morphologic changes on a lateral radiograph of the thor-
acolumbar spine. A vertebral body was considered fractured
if there was a reduction of at least 3 SD in anterior, mid or
posterior ratios compared with normative means [20]. The
information on vertebral fracture was available for a total of
1,746 subjects.
All subjects gave informed consent. The study was ap-
proved by the institutional review board of the Hong Kong
West Cluster Hospitals of the Hospital Authority and the
University of Hong Kong and was conducted according to
the Declaration of Helsinki.
SNP genotyping
A total of 10 SNPs in the POSTN gene were selected for
genotyping: seven tSNPs with reported minor allele fre-
quency (MAF) ≥0.05 in Chinese and three potentially func-
tional SNPs located in exons. The tSNPs were identified
using data from the phase II HapMap CHB (r2≥0.8). SNPs
for HKSC extreme cohort were genotyped using the high-
throughput Sequenom MassARRAY platform (Sequenom,
San Diego, CA, USA). DNA from high and low BMD
subjects were randomly assigned to the 96-well plates and
genotyping performed with sample status blinded. Genotyp-
ing was repeated in 5% of the samples for verification: Data
were confirmed to have an error rate <0.1%. The TaqMan
system (Applied Biosystems, Foster City, CA, USA) was
used for SNP genotyping in the verification and replication
steps.
Statistical methods
Both single marker and haplotype association analyses were
performed using the PLINK software [21]. Any SNP with
call rate <90%, MAF <0.01 or Hardy–Weinberg equilibrium
(HWE) P<0.001 was excluded. The binary logistic regres-
sion was used to test the association between each SNP and
BMD variation of the HKSC extreme cohort and vertebral
fractures under the additive model. The association of SNP
with BMD variation in the replication cohort was detected
by the linear regression analysis. In the block-based haplo-
type association analysis, the haplotype global test is an
omnibus test (if there are H haplotypes, a single test with
H-1 degrees of freedom is conducted). The haplotype-
specific test evaluates each specific haplotype versus all
other haplotypes (i.e., tests with 1 degrees of freedom).
The conditional haplotype testing model was used to assess
the correlation structure and identify which SNP was most
likely to be the causal variant. The hypothesis is that if the
global haplotype association disappears in the omnibus test
when conditioned on SNP “A” but remains significant under
the control of other SNPs, then SNP “A” accounts for the
observed association. The age, height, weight, and gender
were included as covariates in all of the association analy-
ses. Statistical tests were performed for both LS and FN
BMD. The false discovery rate (FDR) method, which is an
effective way to address the problems of multiple compar-
isons, was used in this study to correct for multiple testing.
The imputation of genotypes for untyped SNPs from
HapMap in the POSTN gene and its flanking regions, ap-
proximately 5 kb upstream and downstream, was conducted
by a hidden Markov model programmed in MACH v1.0
[22]. We used the phase II HapMap Asian data (CHB and
JPT) as the reference panel. In brief, this method combines
genotypic data of studied samples with the reference geno-
type data and then infers genotypes of untyped SNPs based
on probability. The most frequently sampled genotype will
be the final imputed one. We used the most likely genotype
for the association analysis. The estimated squared correla-
tion (r2) between imputed and true genotypes was used to
assess the imputation quality in MACH. SNPs with r2<0.3
were defined as low imputation quality and were excluded.
The most significant untyped SNP was validated by direct
genotyping in the HKSC extreme cohort and was replicated
in the HKOS prospective cohort. The weighted z-transform
test was used in the meta-analysis of SNP with BMD vari-
ation in this study.
The interactive effect between POSTN and SOST genes
was evaluated using our GWAS data with about 500K SNPs
in 800 female subjects with extreme BMD that has been
described in detail previously [18]. These 800 GWAS ex-
treme subjects belong to the HKSC extreme cohort, which
was used as the discovery cohort in this study (n01,572).
Several polymorphisms in these two genes showed nomi-
nally significant association with BMD in our GWAS (P<
0.05), although they failed to reach the genome-wide signif-
icant level (Table S3, ESM 1). The most significant SNP of
POSTN from this candidate gene study and four SNPs
(rs9899889, rs865429, rs1234612, and rs2301682) in the
SOST and ∼20 kb flanking regions from the GWAS data
were used for the interaction analysis. The interactions were
assessed by the MDR program [23]. MDR is a nonparamet-
ric data mining approach, which pools multi-locus geno-
types with high dimensions into one dimension model. It
evaluated the predictor using cross-validation method and
permutation testing. The combinatorial examination by
these two approaches would minimize false positive rates.
Cross-validation consistency and testing accuracy were cal-
culated for each combination of tested SNPs. The final best
model was the one with maximal cross-validation consis-
tency and minimal prediction error. The statistical signifi-
cance was assessed by comparing the average prediction
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accuracy from the observed data to the distribution of aver-
age prediction accuracy under the null hypothesis of no
associations derived empirically from 1,000 permutations.
All possible two-, three-, and four-way SNP interactions
were tested using 20-fold cross-validation in an exhaustive
search (considering all possible SNP combinations). The
conditional logistic regression analysis was performed using
SPSS (v16.0) to confirm the reported interactive effects in
MDR, which may be caused by the main effects from the
component loci instead of the epistatic interactions. A logis-
tic regression analysis with P<0.05 could support the
corresponding significant MDR interaction model.
Electrophoretic mobility shift assay
The human complementary DNA clone of CDX1 (pCMV6-
CDX1) was produced by OriGene (OriGene Technologies,
Rockville, MD, USA). CDX1 protein preparation was made
by transfecting pCMV6-CDX1 construct into HEK293 cells
using Lipofectamine 2000 (Invitrogen, Carlsbad, CA,
USA). Cells were harvested 48-h post-transfection, and
nuclear extractions were performed using a nuclear extrac-
tion kit (Panomics, Fremont, CA, USA). Protein concentra-
tion was measured using the DC protein assay kit (Bio-Rad,
Hercules, CA, USA), with bovine serum albumin as a stan-
dard. The following double-stranded oligonucleotides were
synthesized (Sigma-Aldrich Corp., St. Louis, MO, USA)
and used in electrophoretic mobility shift assay (EMSA):
(1) the labeled major allele A probe, corresponding to
POSTN sequences centering rs9547970 (underlined and
bolded in the following sequences), prepared by annealing
of the biotin-labeled oligonucleotide 5 ′-AAAAGA
GAGGTCTTAAATCTTTCTTTTCACACT-3′ with the
complementary sequence 5′-AGTGTGAAAAGAAA
GATTTAAGACCTCTCTTTT-3′; (2) the minor allele G
probe, prepared by annealing the biotin-labeled oligonucleotide
5′-AAAAGAGAGGTCTTGAATCTTTCTTTTCACACT-3′
with the complementary sequences 5′-AGTGTGAAAA
GAAAGATTCAAGACCTCTCTTTT-3′; and (3, 4) the
corresponding unlabeled major allele A and minor allele G
probes.
The EMSAwas performed using the EMSA kit (Panomics,
Fremont, CA, USA). We incubated 10 ng of biotin-labeled
probe with 15.64 μg of nuclear extract of HEK293 cells trans-
fected with pCMV6-CDX1 for 30 min at 15°C in a 10-μl
reaction volume containing 2 μl 5× binding buffer (aqueous
buffered solution for TF binding) and 1 μg poly d(I-C). Nu-
clear extract of untreated HEK293 served as negative control.
For competitive reactions, we used the above unlabeled probe
for competition at 660-fold molar excess of the labeled probe.
After incubation, samples were separated by electrophoresis on
a 6% non-denaturing polyacrylamide gel with 0.5× Tris–bo-
rate–EDTA buffer. DNA–protein complexes were
electroblotted to Pall Biodyne B nylon membrane (Pall Corp.,
Pensacola, FL, USA) and visualized by exposure to Chemilu-
minescent Detection Film (Agfa, Shanghai, China).
Results
The characteristics of the subjects are summarized in Table 1
for both the extreme and prospective cohorts and Table S1
(ESM 1) for the LS and FN sub-groups of the extreme
cohort. The two populations differed in age, height, and
weight, and these three factors were included as covariates
in the association analyses to eliminate their potential con-
founding effects. Two SNPs rs1133973 and rs3205088 were
monomorphic in our population. The remaining eight SNPs
passed the genotyping quality control criteria with the over-
all genotyping call rate >98.7%, duplicate error rate <1%,
MAF >1%, and HWE P>0.001 (Table 2).
Association between POSTN and BMD variation in tSNP-
based analysis
Table 2 lists the single-marker association results with BMD
variation in the extreme cohort. Two tSNPs (rs7322993 and
rs7338244) in the POSTN gene showed significant associa-
tions with BMD variation after the correction of multiple
testing (PFDR<0.05, OR>1). Both of their minor alleles
were related to the higher risk of low BMD. SNP
rs7322993 had the strongest association (P00.001), and
the P values were 0.006 and 0.029 for BMD at LS and
FN, respectively, in site-specific analyses.
We examined the association between common haplo-
types of POSTN and BMD variation. The LD structure of
POSTN is illustrated in Figure S1 (ESM 1). The haplotype
in POSTN was associated with BMD variation in the global
test (P00.038) (Table S2, ESM 1). Table S2 (ESM 1) also
shows the specific effects of each haplotype. Seven haplo-
types were identified, each with a frequency >3%. The
haplotype CGTTGAAG, including both the low BMD-
related alleles of rs7322993 and rs7338244, was most
strongly associated with BMD variation (P00.025) and a
higher risk of low BMD was expected. The haplotype data
corresponded to the single marker analysis, but did not add
further information to outcome.
Validation of rs9547970 with imputation-based association
testing
We used the imputation method to study SNPs that were not
genotyped in our study, but available from the HapMap
database. This enabled a more comprehensive fine map of
polymorphisms along POSTN and a better understanding of
this association. We estimated the strength of evidence for a
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phenotypic association with typed and untyped SNPs locat-
ed between ∼5 kb upstream and ∼5 kb downstream of
POSTN. Sixty-two SNPs from the Asian population data
of HapMap phase II were extracted for imputation. In addi-
tion to the genotyped SNPs, 54 imputed SNPs (MAF≥0.01
and the imputation quality r2≥0.3) were tested for associa-
tions with BMD variation.
The strongest evidence for an association with BMD
variation in the imputed data is undoubtedly for the untyped
SNP rs9547970 (PFDR<0.05), which is located at −2,327 bp
upstream of POSTN (Fig. 1). An additional 27 SNPs dis-
played convincing evidence of association (P<0.005) and
were in high LD (r2>0.5) with rs9547970 based on the
HapMap Asian population data. The most significant
untyped-SNP rs9547970 had a high imputation quality
(r200.9983). Subsequently, it was also directly genotyped
in the 1,572 extreme samples to verify its association with
BMD variation. The frequency of minor allele G (0.265) of
rs9547970 was similar to the MAF of HapMap CHB
(0.233). The results demonstrated the association between
rs9547970 and BMD variation, with P (OR, 95%CI) values
of 6.8×10−4 (1.41, 1.16–1.73) in all subjects, 0.007 (1.38,
1.09–1.76) and 0.019 (1.42, 1.06–1.91) for LS and FN
subgroups, respectively. Its G allele was related to the higher
risk of low BMD (Table 3).
To further explore the relationship between the signifi-
cant SNPs rs7322993, rs7338244, and rs9547970 with
BMD variation, we performed the conditional haplotype
analysis using these three SNPs. The global association
was significant (P<0.01) and remained significant when
conditioned on rs7322993 or rs7338244 (P<0.05) but
disappeared when conditioned on rs9547970 (P>0.1).
This provides further evidence that the significant asso-
ciations of rs7322993 and rs7338244 derive from the
LD correlation with rs9547970 (D′01, r2≥0.5) also that
rs9547970 is the most promising candidate to explain the
identified association.
Replication in an independent population-based cohort
The association between rs9547970 and BMD variation was
replicated in the HKOS prospective cohort. This is a pre-
hypothesis test; thus, one-sided P<0.05 can be taken as a
successful replication. The one-sided P value (beta) was
0.023 (−0.078) for LS BMD and 0.039 (−0.061) for FN
BMD (Table 3). The effect direction of G allele was consis-
tent with the initial analysis in the HKSC extreme subjects,
which was related to low BMD. The effect size of
rs9547970 estimated in the HKSC extreme cohort could
be biased because of selection for extreme subjects. Thus,
we conducted the estimation in our HKOS prospective
cohort, and the allelic variance of rs9547970 of POSTN
explained ∼0.25% and ∼0.15% of BMD variance at LS
and FN, respectively. The raw BMD value was 0.030 and
0.011 (g/cm2) less in minor allele GG carriers compared
with AA carriers for LS and FN, respectively (Fig. S2,
ESM 1). Using weighted z-transform test, the meta-
analyzed P values of rs9547970 were 0.003 and 0.01 for
LS BMD and FN BMD, respectively.
Furthermore, results supported the association of rs9547970
with vertebral fractures even after the adjustment of LS BMD
Table 1 Basic characteristics of two studied cohorts
Hong Kong Southern Chinese extreme cohorta Hong Kong Osteoporosis Study prospective cohortb
High BMD group Low BMD group P value BMD group Vertebral fracture
No fracture group With fracture group P value
Subjects number 663 909 2,509 1,469 277
Age (years) 47.7 (15.46) 50.5 (16.02) <0.05 63.6 (8.81) 62.4 (8.31) 68.0 (9.10) <0.01
Height (m) 1.61 (0.08) 1.55 (0.08) <0.01 1.56 (0.08) 1.57 (0.08) 1.54 (0.08) <0.01
Weight (kg) 63.59 (10.91) 50.73 (8.66) <0.01 57.65 (10.12) 58.04 (10.02) 56.80 (10.77) 0.06
BMD (g/cm2)
Lumbar spine 1.09 (0.13) 0.74 (0.13) <0.01 0.85 (0.18) 0.87 (0.18) 0.80 (0.18) <0.01
Femoral neck 0.86 (0.12) 0.58 (0.09) <0.01 0.65 (0.12) 0.67 (0.12) 0.60 (0.13) <0.01
BMD z-score
Lumbar spine 1.16 (0.84) −1.43 (0.68) <0.01 −0.24 (1.13) −0.17 (1.34) −0.40 (1.25) <0.05
Femoral neck 1.10 (0.82) −1.25 (0.66) <0.01 −0.20 (0.98) −0.11 (0.99) −0.36 (1.03) <0.01
Data are expressed as mean (SD). The t test was conducted for phenotype comparison between high and low BMD groups for extreme cohort and
between groups with and without vertebral fracture for prospective cohort
a The basic characteristics of the lumbar spine and femoral neck sub-groups of the extreme cohort are detailed in Table S1 (ESM 1)
b A total of 2,509 subjects with BMD data were included in the prospective cohort, and 1,746 of them had the data of vertebral fracture
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and the covariates of age, height, weight, and gender (P00.007,
OR 1.33, 95%CI 1.08–1.62, Table 3). Carriers of the minor
allele G per copy of rs9547970 had 1.33 higher risk of vertebral
fracture, consistent with the association of G allele with low
BMD. To detect the effect of age difference between two
groups on vertebral fractures, besides age, the age2 was also
added to the model as a covariate, and the result was similar to
the model without age2. This suggested that the association of
rs9547970 with vertebral fractures was derived from the genet-
ic effect independent of the effect of age.
Interactions between POSTN and SOST genes
A previously functional study on bone metabolism sug-
gested the molecular interaction between POSTN and SOST
[14]. Results from MDR also suggested an interactive effect
of POSTN and SOST genes upon BMD variation (P<0.001).
The best models for each trait were listed in Table 4, of
which two-way SNPs model were associated with BMD
variation in all subjects and four-way model for LS BMD
and three-way model for FN BMD. We validated these three
potential interaction models using the conditional logistic
regression method. Results showed that these three models
were highly supported by logistic regression (P<0.01). The
results from both MDR and conditional logistical regression
analyses indicated the existence of gene–gene interactions
between POSTN and SOST genes influencing BMD
variation.
EMSA showed the disappearance of CDX1 binding site
in the variant allele of rs9547970
To detect the potential function of the identified variant, we
used the FASTSNP program to predict the function of
rs9547970 [24]. Bioinformatics analysis suggests that the
allele change (A/G) at rs9547970 should demolish one bind-
ing site of CDX1 (caudal type homeobox 1) (MIM 600746).
We therefore conducted an EMSA to confirm the potential
changes of CDX1 binding to POSTN caused by rs9547970.
In the gel shift assay (Fig. 2), the 33-bp oligonucleotides
that contained both allelic variants of rs9547970, representing
native and mutated CDX1 binding sites, were assayed with
nuclear extract of HEK293 cells transfected with pCMV-
CDX1. We found a specific binding of CDX1 from nuclear
extract of HEK293 cells transfected with pCMV6-CDX1 to
the wild-type site centering the rs9547970 major allele A of
POSTN. No binding was observed with oligonucleotide con-
taining the minor allele G. Binding to the major A allele
resulted in a complex that was specifically competed by
660-fold excess of unlabeled probe containing the major A
allele. The results indicate that the A/G change at rs9547970
demolishes a CDX1 binding site in the POSTN gene.Ta
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Discussion
We reported the association of common polymorphisms
along the POSTN gene (13q13.3) with osteoporosis pheno-
types. SNP rs9547970 was determined to be the variant that
could best explain the identified association. The EMSA
experiment further demonstrated the specific binding of
CDX1 to sequence around rs9547970 with major allele A.
Previous functional studies have demonstrated the important
role of POSTN in the regulation of osteoblast differentiation
and bone formation [6, 8, 11, 13]. In this study, there was also
evidence to strongly suggest an association of polymorphisms
in thePOSTN gene with osteoporosis phenotypes.We first used
a tSNP-based method to facilitate this association study. This is
sufficient to capture most of the variation in the studied region
and can reduce the genotyping effort for association mapping.
Fig. 1 Association results of BMD variation with single SNPs from the
imputed genotyping data after the adjustment of age, height, weight, and
gender in all of the 1,572 extreme subjects. X-axis the genomic position
(B36); Y-axis the −log10 (P value) of association results (left scale) and the
fine scale recombination rate (B36, right scale); circle dots genotyped
SNPs; square dots untyped SNPs. The colors of dots are coded according
to the degree of linkage disequilibrium (r2) with rs9547970 identified as
the most significant SNP in this study (PFDR<0.05), and this imputed top
SNP was then directly genotyped in the 1,572 extreme subjects for
validation; rs1977278, the SNP had strongest association with BMD
variation in the Framingham Study; rs7322993 and rs7338244, the se-
lected tSNPs showed significant associations with BMD variation after
the correction of multiple testing in the tSNP-based analyses (PFDR<
0.05)
Table 3 Summary of association results of rs9547970 in two studied cohorts
Either LS or FN BMD LS BMD FN BMD Vertebral fracturea
(n01,746)
A1 A2 MAF P value OR (95% CI)/β P value OR (95% CI)/β P value OR (95% CI)/β P value OR (95% CI)
HKSC extreme
cohort (n01,572)
G A 0.265 6.8×10−4 1.41 (1.16–1.73) 0.007 1.38 (1.09–1.76) 0.019 1.42 (1.06–1.91) NA NA
HKOS prospective
cohort (n02,509)
G A 0.278 NA NA 0.023a −0.078b 0.039a −0.061b 0.007 1.33 (1.08–1.62)
Meta-analysisc
(n04,081)
NA NA 0.003 NA 0.010 NA NA NA
The top imputation finding, rs9547970, was validated by direct genotyping in the Hong Kong Southern Chinese (HKSC) extreme cohort and was
replicated in the Hong Kong Osteoporosis Study (HKOS) prospective cohort. The results were adjusted for age, height, weight, gender, and LS
BMD (vertebral fracture only)
A1Minor/effect allele, A2 major allele, MAF minor allele frequency, OR odds ratio; OR >1 the effect allele is associated with the higher risk of low
BMD or vertebral fracture, NA not available
a In the replication cohort (HKOS prospective cohort), the listed P values of BMD were one-sided, as they have the same direction of effect to the
initial analysis in the HKSC extreme cohort. Other P values were all two sided.
b The effects were presented as regression coefficient (β) estimated using the linear regression model.
c The meta-analysis was done using a weighted z-transform test
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The results supported the association of the POSTN gene with
BMD variation from both the single marker (PFDR<0.05) and
haplotype analysis (P<0.05). These tSNP-based results pre-
sumably suggest that the POSTN gene may influence BMD
variation.
The tSNP-based method is a cost-effective approach but
has limitations in the determination of real causal variants.
We therefore used the available data of HapMap Asian
population to study the variation in the POSTN gene with
a much higher coverage. The association analyses of
imputed data revealed the most significant SNP rs9547970
located at −2,327 bp upstream of POSTN. This was
validated by direct genotyping in the HKSC extreme
cohort (P06.8×10−4) and by replication in the HKOS
prospective cohort (one-sided P<0.05) with effect direc-
tion of rs9547970 consistently relating to low BMD.
Our further analysis revealed that rs9547970 was the
most promising candidate causal variant, and the significance
of other SNPs arose from the high LD with rs9547970.
Similar to other susceptible allele, the allelic variance of
rs9547970 explained only a small portion (<0.5%) of the
variance in BMD, but the information from this study adds
to the understanding of the genetic control of BMD and
fracture risk. In addition, we also evaluated the gender-
specific effect of POSTN gene on BMD variation using the
HKSC extreme subjects. Associations were found in female
(P<0.001) while not in male (P>0.05) in gender-specific
analyses, while effects on BMD were not significantly
different between the two genders (P>0.1) in the
gender-interaction analysis using the regression model.
Failure to detect the association in male subjects might
be due to the small number of males in our population.
Furthermore, evidence from the replication step was also
observed for an association of rs9547970 with high risk
of vertebral fractures, consistent with its association
with low BMD. Compared with the modest effect of
POSTN on BMD variation, the very high odds ratio on
vertebral fracture risk is likely due to an overestimation,
as there are several other confounders related to fracture
risk that could not be adjusted in the analysis. Future
study is required to assess the actual effect of POSTN
on fracture determination. However, the findings from
this study suggest that the POSTN gene is likely to play
a contributory role to BMD and fracture risk prediction.
In addition, the association of POSTN with vertebral
fracture remained significance even after the adjustment
of LS BMD. This confirms that BMD alone is inadequate to
comprehensive measure of bone strength and structure
and predict the risk of fracture [25, 26]. These association
results were limited to Chinese population in this study, and
further replications in other ethnic groups are necessary.
The association between POSTN gene and BMD was
supported by previously published genome-wide linkage and
genome-wide association studies. The NEMO Family Study
suggested that the 13q12-14 region may contain quantitative
trait loci linked to BMD variation [27]. According to the
available results from dbGaP, in the 100K association data
Table 4 Interactive effects between POSTN and SOST genes on BMD
variation by MDR and conditional logistic regression analyses
Either LS or FN LS FN
SNP of POSTN rs9547970 rs9547970 rs9547970
SNP of SOST rs2301682 rs9899889 rs9899889
rs865429 rs865429
rs2301682
MDR
Cross validation
consistency
20/20 19/20 20/20
Prediction accuracy 0.57 0.57 0.56
Sign test P-value <0.0001 0.001 0.0087
Conditional logistic regression analysis
P value 0.001 0.002 0.002
Several output parameters are used to select the best interaction model
in MDR. The cross-validation consistency score measures the degree
of consistency with which the reported interaction is identified as the
most evident model. The testing accuracy score measures the degree to
which the interaction accurately predicts case–control status (accuracy
score ≥0.55 is suggested as “interesting”). The best model is the one
with the maximal cross-validation consistency and minimal prediction
error. When cross-validation consistency is higher for one model and
prediction error is lower for another model, the model involving the
fewest loci/factors is taken as the best. The statistical significance (sign
test P value) derived empirically from 1,000 permutations was adjusted
for multiple comparisons
Fig. 2 Electrophoretic mobility shift and competition assays with
nuclear extract of HEK293 cells transfected with pCMV-CDX1 and
allelic variants of SNP rs9547970 in POSTN. 1 Labeled G probe+
nuclear extract(Cdx1−); 2 labeled A probe+nuclear extract (Cdx1−); 3
labeled G probe; 4 labeled G probe+nuclear extract (Cdx1+); 5 labeled
G probe+nuclear extract (Cdx1+)+unlabeled G probe; 6 labeled A
probe; 7 labeled A probe+nuclear extract (Cdx1+); 8 labeled A probe+
nuclear extract (Cdx1+)+unlabeled A probe. Cdx1−, from untreated
HEK293; Cdx1+, from HEK293 transfected with pCMV-CDX1
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of bone mass in the Framingham Heart Study [28], SNPs in
the POSTN gene showed associations with BMD variation,
although they were not prominent in this GWAS. A polymor-
phism rs1977278 was associated with LS BMD (P00.008,
n01,141) using the additive generalized estimating equation
model. Another SNP, rs7336380, showed a modest associa-
tion with LS BMD (P00.018). Both SNP rs1977278 and
rs7336380 are in relative high LD with rs9547970 (r2>0.5)
based on the CHB HapMap data. These two SNPs in our
population was also associated with low LS BMD under the
same direction of effect (P00.012 for rs1977278 and P0
0.013 for rs7336380). The association significance of
rs1977278 and rs7336380 were further supported and
strengthened in the meta-analysis of HKSC extreme cohort
and Framingham Heart Study with P values being 4.82×10−4
and 1.14×10−3 for LS BMD, respectively. Publically avail-
able Caucasian databases from populations with GWAS in
BMD such as the Framingham Heart Study and deCODE
GWAS Study do not have information on rs9547970, and it
would be very interesting to genotype this SNP for replication
studies in Caucasian populations.
Cross-species comparison indicated that the proximal
5 kb upstream of the translational start site of POSTN
comprised evolutionarily conserved domains [29]. SNPs of
the 5′ flanking region may be involved in the regulation of
gene expression. Thus, we searched for possible transcrip-
tion factor binding sites in this region using the FASTSNP
program. Results were confirmed by EMSA experiment and
suggested a putative binding site for CDX1 in the presence
of major allele A, but not the risk allele G. SNP rs9547970
may alter the transcriptional activity of the POSTN gene,
thereby affecting bone formation. The CDX1 gene is a
member of the caudal-related homeobox transcription factor
family. The encoded DNA-binding protein regulates
intestine-specific gene expression and enterocyte differenti-
ation. It induces expression of the intestinal alkaline phos-
phatase gene and inhibits beta-catenin/T-cell factor
transcriptional activity [30]. The functional significance of
Homeobox (Hox) genes in embryonic skeletogenesis has
been well documented by knockout and deficiency studies;
Hox gene expression is reactivated during bone regenera-
tion. The presence of putative Cdx1-binding sites within the
regulatory sequences of Hox genes and in vitro transactiva-
tion of Hoxa-7 by Cdx1 indicates a direct interaction [31,
32]. Further replication and functional analyses are required
to confirm the hypothesis that there is a direct regulation
between CDX1-binding and the expression level of POSTN.
Our comprehensive imputation-based analysis identi-
fied rs9547970 as the variant that best explains the
observed association in this study. Although most promising
as the causal variant, it is also possible that rs9547970
is in LD with other unobserved and independent functional
variants. According to the imputation based analysis,
there was no strong evidence to support this, although
the possibility of other independent rare variants of
MAF <0.01 in the POSTN gene cannot be ruled out.
Resequencing of the entire gene in a large number of
individuals would provide more information to clarify
the association of the POSTN gene with osteoporosis
risk. Our findings were not observed in recently
reported GWAS in Caucasian populations [33–35]. This
may be due to ethnic differences and sampling and
statistical methods. Nevertheless, our study sample was
selected from a large population with relatively high
homogeneity. The selected sampling strategy can
substantially increase power over random sampling for
detection of allelic association [36]. According to the
Genetic Power Calculator [37], our HKSC extreme
cohort has more than 95% power to detect an association for
a functional locus accounting for 1% phenotypic variation
(P00.002, MAF00.3, D′00.8). Moreover, the identified
association was replicated in another independent population
using different genotyping technique and sampling method.
Although GWAS are clearly a major advance for gene
discovery, the results from those studies also suggest that
more osteoporosis-related variants and genes are yet to be
discovered. To date, confirmed loci account for <5% of the
BMD variation in the general population, leaving heritabil-
ity largely unexplained. Many more common variants with
increasingly smaller effects and rare variants with possible
large effects could contribute to the undiscovered genetic
component. In addition, the gene–gene interactions are ac-
knowledged as important contributors to genetic variation in
human complex traits. The functional study in animal mode
demonstrated that the matricelluar Postn protein is required
for Sost inhibition and thereby plays an important role in the
determination of bone mass and microstructural [14]. Being
consistent with the functional finding, our interaction anal-
yses using MDR suggested the existence of interactive
effect between POSTN and SOST genes on BMD variation
(P<0.001), and the results were validated by logistic regres-
sion analyses (P<0.01). This finding supports that BMD
variation may be determined by interactive effects between
candidate genes other than their individual influence and
gene–gene interactive effects could be a significant cause
for BMD variation.
In summary, this study reported the associations of var-
iations along the POSTN gene with low BMD and vertebral
fracture risk.
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